Clinical Trial Update: A Trial to Evaluate Safety, Tolerability, PK and Antiviral Activity of MB-110 in Hepatitis C Virus Infected Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics and antiviral activity of MB-110 in patients with Hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• MB-110

Snippet

Sponsor: Microbio Co Ltd | Conditions: Chronic Hepatitis C | Phase 1 | Status: UNKNOWN